Table of Contents Table of Contents
Previous Page  2244-2245 / 2437 Next Page
Information
Show Menu
Previous Page 2244-2245 / 2437 Next Page
Page Background

28.10.2010

21.5.2010

response to Erlotinib

lung adenocarcinoma with EGFR mutation